Technologies
Title: | ZyCoV-D |
Area: | COVID-19 Technology |
Focus Area: | DNA Vaccine, COVID Vaccine |
Status: | Market Launch |
Patent: | Filed |
Social Benefits: | The plug and play technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in the virus, such as those already occurring. |
Developing Agency: | zydus life, Ahmedabad |
Technology Readiness Index: | TRL-9 |
Brief Description
Description : | Zydus DNA vaccine candidate against SARS-CoV-2, ZyCoV-D is the world’s first and India’s indigenously developed Plasmid DNA vaccine to be administered in humans including children and adults 12 years and above. |